100% Same
Salt CompositionEffectivenessStrength
Top Branded
Substitute
Salt Composition in bothAlmotriptan 6.25mg
Our Recommendation
Almotan 6.25mg Tablet 4s
136+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Treatment of Acute migraine headache
Customers also bought
More About Almigra 6.25mg Tablet
Benefits
In Treatment of Acute migraine headache Almigra 6.25mg Tablet helps improve the flow of blood in your brain and prevents abnormal activity of muscles that triggers migraines. It is a very effective medicine for treating migraine attacks. By preventing and reducing the frequency migraine attacks, the medicine can help you carry out your daily activities and improve your quality of life.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Almigra 6.25mg Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
How it works
Migraine headaches are thought to result from the dilatation of blood vessels in the brain and the release of vasoactive and pro-inflammatory peptides (chemical messenger) from sensory nerve endings. Almigra 6.25mg Tablet is a selective serotonin receptor agonist. It works by constricting (narrowing) these blood vessels and prevents the release of the chemical messenger in the nerve endings, thereby relieving the migraine headaches.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Almigra 6.25mg Tablet . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Seek medical advice from your doctor: Almigra 6.25mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Safe when prescribed by an expert: Almigra 6.25mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Not Safe: Almigra 6.25mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Caution Advised: Almigra 6.25mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Almigra 6.25mg Tablet may be needed. Doctor consultation is advised.
Caution Advised: Almigra 6.25mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Almigra 6.25mg Tablet may be needed. Doctor consultation is advised.
Manufacturer Address
2042 Mukhini Sheri, Kharakuva, Sarkhej,Ahmedabad - 382210, Gujarat , India
References
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 42-43
Almotriptan malate. Spain: Janssen-Ortho, LLC; 2009 (19 Mar. 2019)
Drugs and Lactation Database (LactMed) (19 Feb. 2020)
Central Drugs Standard Control Organisation (CDSCO) (19 Mar. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
